VERACYTE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
VERACYTE, INC. (VCYT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $7.01 per share for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2016-03-14
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2014-03-31 was $2.37, a 14.49% increase year-over-year.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2013-03-31 was $2.07.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2015 was $7.01, a 128.34% increase from fiscal 2014.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2014 was $3.07, a 44.81% increase from fiscal 2013.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2013 was $2.12, a 51.43% increase from fiscal 2012.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2012 was $1.40.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2015-12-31 | $7.01 10-K · filed 2016-03-14 | |||
| 2014-12-31 | $3.07 10-K · filed 2016-03-14 | |||
| 2014-09-30 | $2.84 10-Q · filed 2014-11-13 | |||
| 2014-06-30 | $2.89 10-Q · filed 2014-08-14 | |||
| 2014-03-31 | $2.37 10-Q · filed 2014-05-09 | |||
| 2013-12-31 | $2.12 10-K · filed 2016-03-14 | |||
| 2013-09-30 | $2.24 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | $2.10 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | $2.07 10-Q · filed 2014-05-09 | |||
| 2012-12-31 | $1.40 10-K · filed 2015-03-25 | |||
| 2012-09-30 | $1.38 10-Q · filed 2013-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |